Quince Therapeutics

South San Francisco, United States

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

May 2026

Post-IPO Equity

Biotechnology Health Care Medical Pharmaceutical Therapeutics

Top Investors

Sequoia CapitalBalyasny Asset ManagementCormorant Asset ManagementVerilyPfizer

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Quince Therapeutics

Who are Quince Therapeutics's investors?

Quince Therapeutics's investors include Sequoia Capital, Balyasny Asset Management, Cormorant Asset Management, Verily, Pfizer.

Where is Quince Therapeutics headquartered?

Quince Therapeutics is headquartered in South San Francisco, United States.

What does Quince Therapeutics do?

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

What stage is Quince Therapeutics at?

Quince Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 18, 2026.

MLA

"Quince Therapeutics — Funding & Investors." VCBacked, May 18, 2026, https://www.vcbacked.co/company/quince-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Quince Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/quince-therapeutics

Wikipedia (cite web)

{{cite web |title=Quince Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quince-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 18, 2026.

Similar Companies in Biotechnology